NCT06690424View on ClinicalTrials.gov

Clinical Studies of the Efficacy and Safety of Remimazolam for Anesthesia Induction and Maintenance in Elderly Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Efficacy and Safety
Interventions
DRUG

Remimazolam

remimazolam 0.2mg / kg was injected IV during the induction of anesthesia，and remimazolam 0.3-0.5mg / kg / h was administered IV during anesthesia maintenance.

DRUG

Propofol

Propofol 1.5-2mg / kg was injected IV during the induction of anesthesia，and Propofol 2-3mg / kg / h was administered IV during anesthesia maintenance.

Trial Locations (1)

226001

RECRUITING

Affiliated Hospital of Affiliated Hospital, Nantong

All Listed Sponsors
lead

Affiliated Hospital of Nantong University

OTHER